MIRUM PHARMACEUTICALS INC (MIRM) Stock Earnings & Estimates
NASDAQ:MIRM - US6047491013 - Common Stock
73.87 USD
-1.66 (-2.2%)
73.87 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 77.06M 302.61% | 186.374M 141.86% | 336.888M 80.76% | 514.45M 52.71% | 615.85M 19.71% | 724.21M 17.60% | 888.07M 22.63% | 1.04B 17.11% | 1.187B 14.13% | 1.348B 13.56% | 1.477B 9.57% | |
| EBITDA YoY % growth | -127.98M 25.94% | -98.325M 23.17% | -63.977M 34.93% | -34.37M 46.28% | 3.705M 110.78% | 49.904M 1,246.94% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -131.22M 24.33% | -109.154M 16.82% | -87.606M 19.74% | -36.126M 58.76% | 1.889M 105.23% | 62.589M 3,213.34% | 160.57M 156.55% | 298.17M 85.69% | 410.06M 37.53% | 539.47M 31.56% | 629.06M 16.61% | |
| Operating Margin | -170.28% | -58.57% | -26.00% | -7.02% | 0.31% | 8.64% | 18.08% | 28.67% | 34.55% | 40.02% | 42.59% | |
| EPS YoY % growth | -4.02 36.74% | -3.97 1.17% | -1.85 53.40% | -0.79 57.35% | -0.21 73.07% | 0.90 523.43% | 1.70 88.78% | 3.40 100.00% | 5.15 51.50% | 6.61 28.44% | 7.63 15.51% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 43.86% | -0.16 68.17% | -0.09 70.15% | -0.04 69.23% | -0.03 80.98% | 0.05 129.30% |
| Revenue Q2Q % growth | 131.75M 45.78% | 138.63M 39.45% | 142.41M 27.62% | 149.89M 17.30% | 151.81M 15.23% | 159.49M 15.05% |
| EBITDA Q2Q % growth | 18.868M 285.93% | 22.629M 3,916.02% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.858M 38.05% | -5.535M 77.15% | -3.975M 73.82% | -731.003K 85.35% | -6.473M 17.62% | -3.226M 41.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.12 76.92% | -0.33 | 0.21 | 63.96% |
| Q1 2025 Q2Q % growth | -0.30 44.44% | -0.34 | 0.04 | 10.69% |
| Q4 2024 Q2Q % growth | -0.49 25.76% | -0.25 | -0.24 | -99.42% |
| Q3 2024 Q2Q % growth | -0.30 47.37% | -0.46 | 0.16 | 34.54% |
| Q2 2024 Q2Q % growth | -0.52 73.20% | -0.48 | -0.04 | -7.94% |
| Q1 2024 Q2Q % growth | -0.54 32.50% | -0.49 | -0.05 | -10.52% |
| Q4 2023 Q2Q % growth | -0.66 33.13% | -0.25 | -0.41 | -166.28% |
| Q3 2023 Q2Q % growth | -0.57 44.12% | -0.64 | 0.07 | 11.08% |
| Q2 2023 Q2Q % growth | -1.94 -130.95% | -0.81 | -1.13 | -139.12% |
| Q1 2023 Q2Q % growth | -0.80 31.62% | -0.96 | 0.16 | 16.41% |
| Q4 2022 Q2Q % growth | -0.99 40.54% | -1.04 | 0.05 | 4.80% |
| Q3 2022 Q2Q % growth | -1.02 34.19% | -1.09 | 0.07 | 6.52% |
| Q2 2022 Q2Q % growth | -0.84 42.07% | -1.18 | 0.34 | 28.60% |
| Q1 2022 Q2Q % growth | -1.17 30.77% | -1.37 | 0.20 | 14.40% |
| Q4 2021 Q2Q % growth | -1.66 -16.08% | 0.35 | -2.01 | -571.72% |
| Q3 2021 Q2Q % growth | -1.55 -80.23% | -1.76 | 0.21 | 11.99% |
| Q2 2021 Q2Q % growth | -1.45 -55.91% | -0.66 | -0.79 | -119.27% |
| Q1 2021 Q2Q % growth | -1.69 -96.51% | -0.71 | -0.98 | -138.40% |
| Q4 2020 Q2Q % growth | -1.43 -81.01% | -0.73 | -0.70 | -94.91% |
| Q3 2020 Q2Q % growth | -0.86 -2.38% | -0.99 | 0.13 | 13.55% |
| Q2 2020 Q2Q % growth | -0.93 82.49% | -0.88 | -0.05 | -5.22% |
| Q1 2020 Q2Q % growth | -0.86 | -0.83 | -0.03 | -3.17% |
| Q4 2019 Q2Q % growth | -0.79 | -0.87 | 0.08 | 8.91% |
| Q3 2019 Q2Q % growth | -0.84 | -0.61 | -0.23 | -38.47% |
| Q2 2019 Q2Q % growth | -5.31 | -0.59 | -4.72 | -806.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 127.785M 64.09% | 110.33M | 17.455M | 15.82% |
| Q1 2025 Q2Q % growth | 111.585M 61.20% | 100.37M | 11.215M | 11.17% |
| Q4 2024 Q2Q % growth | 99.414M 42.93% | 98.538M | 876K | 0.89% |
| Q3 2024 Q2Q % growth | 90.377M 89.37% | 83.656M | 6.721M | 8.03% |
| Q2 2024 Q2Q % growth | 77.875M 107.68% | 76.751M | 1.124M | 1.46% |
| Q1 2024 Q2Q % growth | 69.222M 119.07% | 71.575M | -2.353M | -3.29% |
| Q4 2023 Q2Q % growth | 69.554M 149.21% | 69.273M | 281K | 0.41% |
| Q3 2023 Q2Q % growth | 47.725M 154.13% | 39.371M | 8.354M | 21.22% |
| Q2 2023 Q2Q % growth | 37.497M 114.51% | 31.052M | 6.445M | 20.76% |
| Q1 2023 Q2Q % growth | 31.598M 145.14% | 29.269M | 2.329M | 7.96% |
| Q4 2022 Q2Q % growth | 27.91M 788.85% | 25.058M | 2.852M | 11.38% |
| Q3 2022 Q2Q % growth | 18.78M 275.60% | 21.224M | -2.444M | -11.52% |
| Q2 2022 Q2Q % growth | 17.48M 58.91% | 15.725M | 1.755M | 11.16% |
| Q1 2022 Q2Q % growth | 12.89M | 8.632M | 4.258M | 49.33% |
| Q4 2021 Q2Q % growth | 3.14M | 63.903M | -60.763M | -95.09% |
| Q3 2021 Q2Q % growth | 5M | 849.997K | 4.15M | 488.24% |
| Q2 2021 Q2Q % growth | 11M | 14.79M | -3.79M | -25.63% |
| Q1 2021 Q2Q % growth | 8.5M | -8.5M | -100.00% | |
| Q4 2020 Q2Q % growth | 10.2M | -10.2M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 39.37% | -25.63% | 30.39% | 19.2% |
| Revenue | 14.48% | 15.85% | 11.66% | 13.98% |